Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.21 trillion and total revenue of $109.89 billion.
Market Cap
1.21T
Revenue
109.89B
Profits
-41.55B
PE Ratio
n/a
Profit Margin
-37.81%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 120.97B | 1.75% | 198,208 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 63.51B | 1.01% | 120,754 | 14.92B |
| 3 | ARGX | argenx SE | 57.55B | 0.88% | 221,527 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.00B | 3.95% | 177,721 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 35.65B | -1.08% | 710,519 | - |
| 6 | RPRX | Royalty Pharma plc | 31.62B | -0.78% | 1,133,127 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 31.11B | 1.33% | 46,025 | 5.70B |
| 8 | MRNA | Moderna, Inc. | 24.63B | 1.78% | 1,172,500 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 23.71B | 2.36% | 1,504,616 | 8.26M |
| 10 | BNTX | BioNTech SE | 22.85B | -0.30% | 280,879 | 3.23B |
| 11 | INSM | Insmed Incorporated | 22.77B | 2.85% | 606,745 | 819.56M |
| 12 | INCY | Incyte Corporation | 21.54B | 3.30% | 347,636 | 5.36B |
| 13 | GMAB | Genmab A/S | 15.97B | -0.12% | 469,527 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.88B | 0.44% | 63,736 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.55B | 0.74% | 103,426 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.70B | 1.92% | 337,397 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.10B | 1.52% | 304,376 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.69B | 1.04% | 348,698 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.57B | 0.93% | 135,631 | 708.24M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.95B | 0.97% | 51,117 | 1.13B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.57B | 2.84% | 265,110 | 622.01M |
| 22 | SMMT | Summit Therapeutics Inc. | 11.15B | 0.84% | 942,948 | - |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 11.03B | 0.99% | 269,227 | 3.24B |
| 24 | CYTK | Cytokinetics, Incorporated | 11.03B | 1.51% | 531,233 | 105.82M |
| 25 | KRYS | Krystal Biotech, Inc. | 10.39B | 3.60% | 78,946 | 417.30M |
| 26 | APGE | Apogee Therapeutics, Inc. | 9.96B | 0.06% | 1,607,029 | - |
| 27 | NUVL | Nuvalent, Inc. | 9.76B | 0.06% | 847,672 | - |
| 28 | TECH | Bio-Techne Corporation | 9.25B | 5.01% | 417,459 | 1.21B |
| 29 | CORT | Corcept Therapeutics Incorporated | 8.71B | 1.61% | 117,653 | 769.10M |
| 30 | PRAX | Praxis Precision Medicines, Inc. | 8.70B | 2.17% | 64,519 | 7.46M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 8.39B | 1.58% | 220,849 | 1.51B |
| 32 | KYMR | Kymera Therapeutics, Inc. | 8.25B | 2.12% | 116,376 | 51.48M |
| 33 | IBRX | ImmunityBio, Inc. | 8.09B | 5.46% | 3,854,607 | 140.98M |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 7.88B | 3.06% | 111,229 | 74.06M |
| 35 | IMVT | Immunovant, Inc. | 7.87B | 1.83% | 161,699 | - |
| 36 | ABVX | ABIVAX Société Anonyme | 7.77B | -10.38% | 3,696,089 | 5.67M |
| 37 | TGTX | TG Therapeutics, Inc. | 7.74B | 1.28% | 538,650 | 700.35M |
| 38 | PCVX | Vaxcyte, Inc. | 7.69B | 2.51% | 205,510 | - |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.57B | 4.02% | 222,519 | 217.17M |
| 40 | SYRE | Spyre Therapeutics, Inc. | 7.52B | -10.79% | 1,734,859 | - |
| 41 | PTCT | PTC Therapeutics, Inc. | 7.00B | 2.75% | 821,029 | 827.11M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.89B | 1.74% | 90,904 | 569.61M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.49B | 4.65% | 735,663 | - |
| 44 | CNTA | Centessa Pharmaceuticals plc | 6.27B | - | - | 15.00M |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.26B | 1.83% | 534,908 | - |
| 46 | CGON | CG Oncology, Inc. | 6.09B | 4.97% | 188,715 | 5.07M |
| 47 | BLTE | Belite Bio, Inc | 5.87B | 2.85% | 75,697 | - |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 5.72B | 2.14% | 97,658 | 274.48M |
| 49 | LEGN | Legend Biotech Corporation | 5.52B | 1.40% | 395,130 | 1.14B |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.45B | 3.22% | 258,265 | 7.50M |
| 51 | CRSP | CRISPR Therapeutics AG | 5.32B | 2.24% | 370,515 | 4.10M |
| 52 | TVTX | Travere Therapeutics, Inc. | 5.31B | 2.07% | 479,160 | 536.20M |
| 53 | CAI | Caris Life Sciences, Inc. | 5.20B | 4.60% | 321,955 | 907.29M |
| 54 | ORKA | Oruka Therapeutics, Inc. | 5.16B | 2.52% | 350,911 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.98B | 4.07% | 313,199 | 1.34M |
| 56 | DFTX | Definium Therapeutics, Inc. | 4.74B | 20.23% | 6,570,634 | - |
| 57 | ERAS | Erasca, Inc. | 4.72B | 0.80% | 1,293,026 | - |
| 58 | CELC | Celcuity Inc. | 4.67B | 6.11% | 249,172 | - |
| 59 | MANE | Veradermics, Incorporated | 4.64B | 7.15% | 218,514 | - |
| 60 | EWTX | Edgewise Therapeutics, Inc. | 4.36B | 4.35% | 148,813 | - |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.28B | 5.92% | 1,080,585 | - |
| 62 | TNGX | Tango Therapeutics, Inc. | 4.19B | 2.08% | 955,907 | 56.99M |
| 63 | DNLI | Denali Therapeutics Inc. | 4.06B | 3.27% | 251,834 | - |
| 64 | RLAY | Relay Therapeutics, Inc. | 4.06B | 6.71% | 1,004,932 | 10.68M |
| 65 | ACAD | ACADIA Pharmaceuticals Inc. | 4.01B | 3.63% | 318,626 | 1.10B |
| 66 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | 2.37% | 318,449 | 18.07M |
| 67 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | -0.02% | 182,488 | 596.96M |
| 68 | NAMS | NewAmsterdam Pharma Company N.V. | 3.84B | 4.65% | 164,298 | 22.57M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.70B | 6.76% | 72,905 | 803.79M |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.65B | 2.91% | 265,614 | 236.00M |
| 71 | BEAM | Beam Therapeutics Inc. | 3.56B | 7.86% | 852,876 | 164.01M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.46B | 3.36% | 311,321 | - |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 3.46B | 5.29% | 250,493 | 415.62M |
| 74 | PBLS | Parabilis Medicines, Inc. | 3.46B | -1.31% | 144,448 | - |
| 75 | GPCR | Structure Therapeutics Inc. | 3.35B | 3.49% | 94,744 | - |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 3.22B | 5.01% | 448,696 | 225.27M |
| 77 | ALMS | Alumis Inc. | 3.16B | 1.06% | 133,947 | 8.40M |
| 78 | QURE | uniQure N.V. | 3.06B | -1.07% | 1,959,526 | 18.09M |
| 79 | ELVN | Enliven Therapeutics, Inc. | 3.02B | 1.93% | 385,784 | - |
| 80 | RARE | Ultragenyx Pharmaceutical Inc. | 2.95B | 4.31% | 526,066 | 670.00M |
| 81 | TARS | Tarsus Pharmaceuticals, Inc. | 2.94B | 3.34% | 180,522 | 535.08M |
| 82 | KLRA | Kailera Therapeutics, Inc. | 2.91B | 5.05% | 34,789 | - |
| 83 | VERA | Vera Therapeutics, Inc. | 2.85B | 3.78% | 517,746 | - |
| 84 | IRON | Disc Medicine, Inc. | 2.72B | 1.12% | 158,327 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.64B | 2.00% | 123,295 | 865.00K |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.53B | 2.36% | 282,097 | - |
| 87 | AUPH | Aurinia Pharmaceuticals Inc. | 2.47B | 7.38% | 1,096,708 | 298.30M |
| 88 | PHVS | Pharvaris N.V. | 2.35B | 1.30% | 52,543 | - |
| 89 | KOD | Kodiak Sciences Inc. | 2.35B | 1.40% | 78,054 | - |
| 90 | NUVB | Nuvation Bio Inc. | 2.28B | 8.53% | 1,918,932 | 143.05M |
| 91 | BHVN | Biohaven Ltd. | 2.26B | 1.59% | 390,378 | - |
| 92 | MBX | MBX Biosciences, Inc. | 2.25B | 2.00% | 186,392 | - |
| 93 | NKTR | Nektar Therapeutics | 2.22B | -1.38% | 197,429 | 55.63M |
| 94 | IMNM | Immunome, Inc. | 2.21B | 1.14% | 193,909 | 4.02M |
| 95 | OCUL | Ocular Therapeutix, Inc. | 2.21B | -0.35% | 459,147 | 52.04M |
| 96 | NTLA | Intellia Therapeutics, Inc. | 2.21B | 3.54% | 932,520 | 66.09M |
| 97 | AGIO | Agios Pharmaceuticals, Inc. | 2.17B | 2.39% | 303,420 | 66.05M |
| 98 | MLYS | Mineralys Therapeutics, Inc. | 2.15B | 1.80% | 174,899 | - |
| 99 | VCEL | Vericel Corporation | 2.13B | 3.17% | 152,593 | 292.09M |
| 100 | GENB | Generate Biomedicines, Inc. | 2.09B | 5.64% | 130,611 | 30.30M |
| 101 | ZLAB | Zai Lab Limited | 2.06B | -0.70% | 277,997 | 453.28M |
| 102 | NRIX | Nurix Therapeutics, Inc. | 2.05B | 4.93% | 228,531 | 71.78M |
| 103 | ADMA | ADMA Biologics, Inc. | 2.04B | 1.38% | 473,934 | 509.86M |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 2.01B | 1.89% | 71,897 | 899.11M |
| 105 | TSHA | Taysha Gene Therapies, Inc. | 2.01B | 1.75% | 201,844 | 7.47M |
| 106 | MESO | Mesoblast Limited | 2.00B | 2.50% | 54,893 | 65.38M |
| 107 | IOVA | Iovance Biotherapeutics, Inc. | 1.97B | -0.68% | 4,459,426 | 285.61M |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.97B | 1.54% | 105,373 | 32.08M |
| 109 | RAPP | Rapport Therapeutics, Inc. | 1.94B | 4.42% | 126,761 | 20.00M |
| 110 | KARD | Kardigan, Inc. | 1.93B | -2.71% | 143,619 | - |
| 111 | PGEN | Precigen, Inc. | 1.93B | 1.12% | 848,871 | 31.60M |
| 112 | VRDN | Viridian Therapeutics, Inc. | 1.93B | 0.98% | 259,925 | 70.92M |
| 113 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -0.03% | 31,512 | 1.20B |
| 114 | TYRA | Tyra Biosciences, Inc. | 1.84B | 3.13% | 56,962 | - |
| 115 | SRPT | Sarepta Therapeutics, Inc. | 1.82B | - | 406,028 | 2.18B |
| 116 | GLUE | Monte Rosa Therapeutics, Inc. | 1.82B | 3.77% | 400,516 | 42.95M |
| 117 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | 4.28% | 267,724 | 217.17M |
| 118 | ABCL | AbCellera Biologics Inc. | 1.80B | 4.62% | 2,633,812 | 79.21M |
| 119 | NBTX | Nanobiotix S.A. | 1.80B | -6.34% | 17,658 | 38.27M |
| 120 | SION | Sionna Therapeutics, Inc. | 1.79B | -0.29% | 112,428 | - |
| 121 | ZYME | Zymeworks Inc. | 1.78B | 2.32% | 70,866 | 81.26M |
| 122 | INVA | Innoviva, Inc. | 1.76B | 1.15% | 68,269 | 420.69M |
| 123 | VIR | Vir Biotechnology, Inc. | 1.75B | 1.97% | 402,468 | 65.50M |
| 124 | PVLA | Palvella Therapeutics, Inc. | 1.75B | 2.59% | 29,177 | - |
| 125 | ANAB | AnaptysBio, Inc. | 1.74B | 0.63% | 45,518 | 232.39M |
| 126 | URGN | UroGen Pharma Ltd. | 1.73B | 0.85% | 68,060 | 140.49M |
| 127 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | 2.85% | 5,304,657 | 66.41M |
| 128 | CAPR | Capricor Therapeutics, Inc. | 1.72B | 0.44% | 185,480 | 11.13M |
| 129 | BCAX | Bicara Therapeutics Inc. | 1.70B | 3.52% | 165,919 | - |
| 130 | GHRS | GH Research PLC | 1.66B | 2.33% | 27,762 | - |
| 131 | SLS | SELLAS Life Sciences Group, Inc. | 1.66B | -1.87% | 1,697,010 | - |
| 132 | FTRE | Fortrea Holdings Inc. | 1.65B | 5.77% | 517,269 | 2.71B |
| 133 | SEPN | Septerna, Inc. | 1.63B | -0.90% | 66,862 | 72.26M |
| 134 | AVBP | ArriVent BioPharma, Inc. | 1.58B | 0.39% | 243,418 | - |
| 135 | ARDX | Ardelyx, Inc. | 1.56B | 1.94% | 566,580 | 427.68M |
| 136 | ATAI | AtaiBeckley Inc. | 1.54B | 2.20% | 1,431,037 | 3.49M |
| 137 | AKTS | Aktis Oncology, Inc. | 1.52B | 2.02% | 56,163 | 8.28M |
| 138 | IMCR | Immunocore Holdings plc | 1.52B | 2.12% | 114,511 | 412.81M |
| 139 | NVAX | Novavax, Inc. | 1.51B | 1.83% | 817,392 | 596.34M |
| 140 | AAPG | Ascentage Pharma Group International | 1.49B | 0.18% | 2,353 | 82.08M |
| 141 | MAZE | Maze Therapeutics, Inc. | 1.48B | 0.98% | 115,589 | 20.00M |
| 142 | SVRA | Savara Inc. | 1.47B | 0.52% | 302,097 | - |
| 143 | MLTX | MoonLake Immunotherapeutics | 1.46B | -6.86% | 2,951,248 | - |
| 144 | DMRA | Damora Therapeutics, Inc. | 1.45B | 2.42% | 75,653 | - |
| 145 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.44B | 3.54% | 421,806 | 204.73M |
| 146 | ABSI | Absci Corporation | 1.42B | 22.94% | 18,486,367 | 1.84M |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.41B | 3.26% | 61,382 | 1.30M |
| 148 | IMTX | Immatics N.V. | 1.37B | 1.11% | 149,973 | 43.00M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.36B | 0.94% | 22,563 | - |
| 150 | JBIO | Jade Biosciences, Inc. | 1.36B | 3.91% | 297,657 | - |
| 151 | MPLT | MapLight Therapeutics, Inc. | 1.31B | 1.08% | 65,824 | - |
| 152 | COAG | Hemab Therapeutics Holdings, Inc. | 1.31B | 1.30% | 11,498 | - |
| 153 | ZBIO | Zenas BioPharma, Inc. | 1.30B | 1.86% | 37,632 | 10.00M |
| 154 | EYPT | EyePoint, Inc. | 1.24B | 2.54% | 105,211 | 7.61M |
| 155 | MNKD | MannKind Corporation | 1.22B | 0.76% | 440,509 | 360.78M |
| 156 | WVE | Wave Life Sciences Ltd. | 1.17B | 0.83% | 1,082,343 | 71.80M |
| 157 | MGTX | MeiraGTx Holdings plc | 1.13B | 3.39% | 188,919 | 79.76M |
| 158 | CGEM | Cullinan Therapeutics, Inc. | 1.12B | 2.93% | 199,274 | - |
| 159 | XNCR | Xencor, Inc. | 1.10B | 5.26% | 123,135 | 97.36M |
| 160 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | 2.30% | 175,679 | - |
| 161 | SPRY | ARS Pharmaceuticals, Inc. | 1.06B | 3.50% | 379,313 | 98.99M |
| 162 | SANA | Sana Biotechnology, Inc. | 1.05B | 4.48% | 799,537 | - |
| 163 | SPTX | Seaport Therapeutics, Inc. | 1.05B | 3.16% | 33,564 | - |
| 164 | LXRX | Lexicon Pharmaceuticals, Inc. | 999.44M | 4.17% | 876,896 | 69.64M |
| 165 | KURA | Kura Oncology, Inc. | 968.53M | 5.11% | 241,000 | 71.64M |
| 166 | DBVT | DBV Technologies S.A. | 968.08M | -0.16% | 71,921 | 5.74M |
| 167 | ORIC | ORIC Pharmaceuticals, Inc. | 967.37M | 4.88% | 170,060 | - |
| 168 | OLMA | Olema Pharmaceuticals, Inc. | 966.50M | 5.08% | 248,061 | - |
| 169 | REPL | Replimune Group, Inc. | 960.32M | 1.84% | 601,464 | - |
| 170 | AVTX | Avalo Therapeutics, Inc. | 958.80M | 2.30% | 113,089 | 59.00K |
| 171 | PHAR | Pharming Group N.V. | 931.75M | 2.72% | 2,226 | 369.49M |
| 172 | ANRO | Alto Neuroscience, Inc. | 922.44M | 7.55% | 55,070 | - |
| 173 | ODTX | Odyssey Therapeutics, Inc. | 921.89M | 3.80% | 67,203 | 1.06M |
| 174 | EVMN | Evommune, Inc. | 912.89M | 4.52% | 103,031 | 10.00M |
| 175 | ANNX | Annexon, Inc. | 910.96M | 5.30% | 1,145,000 | - |
| 176 | DSGN | Design Therapeutics, Inc. | 910.00M | 6.04% | 145,609 | - |
| 177 | JANX | Janux Therapeutics, Inc. | 908.36M | -0.10% | 361,631 | 13.73M |
| 178 | DRTS | Alpha Tau Medical Ltd. | 906.72M | 2.60% | 207,400 | - |
| 179 | GERN | Geron Corporation | 894.92M | 3.33% | 3,736,016 | 196.12M |
| 180 | LBRX | LB Pharmaceuticals Inc | 894.71M | 1.96% | 46,203 | - |
| 181 | TBPH | Theravance Biopharma, Inc. | 888.26M | 1.53% | 51,177 | 109.78M |
| 182 | SLDB | Solid Biosciences Inc. | 883.09M | 2.05% | 413,313 | - |
| 183 | PHAT | Phathom Pharmaceuticals, Inc. | 881.67M | 2.21% | 177,764 | 204.89M |
| 184 | ABUS | Arbutus Biopharma Corporation | 872.13M | -0.79% | 519,571 | 191.45M |
| 185 | VOR | Vor Biopharma Inc. | 804.12M | -0.07% | 118,996 | - |
| 186 | AURA | Aura Biosciences, Inc. | 797.46M | 2.99% | 46,805 | - |
| 187 | ZVRA | Zevra Therapeutics, Inc. | 779.73M | 1.46% | 210,834 | 122.29M |
| 188 | OMER | Omeros Corporation | 770.80M | 1.62% | 196,373 | 9.89M |
| 189 | IVA | Inventiva S.A. | 750.68M | -3.50% | 260,326 | 7.94M |
| 190 | ALLO | Allogene Therapeutics, Inc. | 724.82M | 1.45% | 1,006,336 | 22.00K |
| 191 | RLMD | Relmada Therapeutics, Inc. | 721.64M | 1.62% | 191,714 | - |
| 192 | CTMX | CytomX Therapeutics, Inc. | 720.60M | 5.08% | 584,086 | 35.54M |
| 193 | CLYM | Climb Bio, Inc. | 705.16M | 0.12% | 321,513 | - |
| 194 | IMMX | Immix Biopharma, Inc. | 704.78M | -0.10% | 187,911 | - |
| 195 | OCS | Oculis Holding AG | 701.71M | -0.85% | 70,430 | 1.40M |
| 196 | TENX | Tenax Therapeutics, Inc. | 689.74M | -1.03% | 158,116 | - |
| 197 | CADL | Candel Therapeutics, Inc. | 684.34M | 2.86% | 271,199 | - |
| 198 | ACRS | Aclaris Therapeutics, Inc. | 678.77M | -1.22% | 473,314 | 8.37M |
| 199 | CRMD | CorMedix Inc. | 677.04M | 0.35% | 148,565 | 400.05M |
| 200 | RIGL | Rigel Pharmaceuticals, Inc. | 676.07M | 2.61% | 49,766 | 299.77M |
| 201 | SGP | SpyGlass Pharma, Inc. | 662.35M | 0.74% | 8,732 | - |
| 202 | FTH | Faeth Therapeutics, Inc. | 659.42M | 6.58% | 27,196 | - |
| 203 | DRUG | Bright Minds Biosciences Inc. | 655.78M | -0.47% | 56,426 | - |
| 204 | AGMB | AgomAb Therapeutics NV | 650.07M | 10.55% | 33,611 | - |
| 205 | SLBT | SL Science Holding Limited | 630.34M | -1.52% | 41,562 | - |
| 206 | TRAX | First Tracks Biotherapeutics, Inc. | 625.27M | 0.79% | 42,622 | - |
| 207 | PRME | Prime Medicine, Inc. | 610.49M | 4.32% | 789,979 | 4.03M |
| 208 | FDMT | 4D Molecular Therapeutics, Inc. | 601.18M | -0.86% | 177,575 | 88.24M |
| 209 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 598.40M | -0.40% | 53,576 | - |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 593.15M | 2.48% | 213,218 | 151.40M |
| 211 | TECX | Tectonic Therapeutic, Inc. | 588.34M | 1.93% | 11,784 | - |
| 212 | ALT | Altimmune, Inc. | 583.42M | 3.09% | 856,287 | 36.00K |
| 213 | CBIO | Crescent Biopharma, Inc. | 577.19M | -0.74% | 17,016 | 11.88M |
| 214 | GYRE | Gyre Therapeutics, Inc. | 574.27M | 2.53% | 16,900 | 117.05M |
| 215 | MNPR | Monopar Therapeutics Inc. | 573.75M | 4.75% | 37,441 | - |
| 216 | MDXG | MiMedx Group, Inc. | 570.46M | 2.68% | 175,441 | 389.42M |
| 217 | RGNX | REGENXBIO Inc. | 555.75M | 8.04% | 579,533 | 87.82M |
| 218 | NVCT | Nuvectis Pharma, Inc. | 550.27M | 18.21% | 246,346 | - |
| 219 | RZLT | Rezolute, Inc. | 541.14M | 5.93% | 392,347 | - |
| 220 | ASMB | Assembly Biosciences, Inc. | 538.73M | 1.44% | 36,175 | 71.10M |
| 221 | ACHV | Achieve Life Sciences, Inc. | 536.91M | 4.39% | 517,147 | - |
| 222 | EIKN | Eikon Therapeutics, Inc. | 530.56M | 3.05% | 27,850 | - |
| 223 | XOMA | XOMA Royalty Corporation | 528.17M | 0.39% | 52,213 | 48.56M |
| 224 | ARVN | Arvinas, Inc. | 526.49M | 0.25% | 173,906 | 89.40M |
| 225 | PROK | ProKidney Corp. | 521.05M | -4.17% | 138,647 | 889.00K |
| 226 | KYTX | Kyverna Therapeutics, Inc. | 519.19M | 1.30% | 148,939 | - |
| 227 | STRO | Sutro Biopharma, Inc. | 516.83M | 6.85% | 61,641 | 99.61M |
| 228 | PRTA | Prothena Corporation plc | 507.83M | 1.57% | 103,274 | 57.94M |
| 229 | CABA | Cabaletta Bio, Inc. | 498.95M | 1.32% | 681,864 | - |
| 230 | VALN | Valneva SE | 498.24M | -1.48% | 2,547 | 180.25M |
| 231 | NGNE | Neurogene Inc. | 493.41M | 1.18% | 24,175 | 925.00K |
| 232 | ARTV | Artiva Biotherapeutics, Inc. | 484.42M | 1.73% | 119,302 | 251.00K |
| 233 | OCGN | Ocugen, Inc. | 475.62M | 1.81% | 1,296,844 | 4.47M |
| 234 | CCCC | C4 Therapeutics, Inc. | 474.33M | 1.66% | 680,184 | 34.86M |
| 235 | CTNM | Contineum Therapeutics, Inc. | 472.56M | 6.13% | 51,358 | - |
| 236 | EDIT | Editas Medicine, Inc. | 451.18M | 6.52% | 1,347,950 | 38.69M |
| 237 | OVID | Ovid Therapeutics Inc. | 448.87M | 3.66% | 468,042 | 7.12M |
| 238 | FBRX | Forte Biosciences, Inc. | 447.42M | 0.88% | 13,550 | - |
| 239 | BNTC | Benitec Biopharma Inc. | 446.95M | 1.01% | 20,530 | - |
| 240 | IPSC | Century Therapeutics, Inc. | 442.77M | 1.87% | 253,105 | 109.16M |
| 241 | PRLD | Prelude Therapeutics Incorporated | 442.33M | 1.83% | 24,092 | 16.72M |
| 242 | VTVT | vTv Therapeutics Inc. | 441.78M | 0.78% | 25,899 | 36.84M |
| 243 | SGMT | Sagimet Biosciences Inc. | 440.29M | 0.99% | 78,679 | - |
| 244 | AUTL | Autolus Therapeutics plc | 428.49M | -3.01% | 295,488 | 92.62M |
| 245 | STTK | Shattuck Labs, Inc. | 427.88M | 3.53% | 92,982 | 1.00M |
| 246 | INDP | Indaptus Therapeutics, Inc. | 424.66M | 1.08% | 7,985 | - |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 421.01M | 0.63% | 59,334 | - |
| 248 | ANL | Adlai Nortye Ltd. | 416.80M | -1.70% | 10,441 | 5.00M |
| 249 | PBYI | Puma Biotechnology, Inc. | 410.50M | 0.31% | 169,246 | 227.18M |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 408.55M | -0.07% | 108,584 | 69.21M |
| 251 | SLN | Silence Therapeutics plc | 402.91M | 17.33% | 279,312 | 839.00K |
| 252 | ZURA | Zura Bio Limited | 399.94M | -2.21% | 187,090 | - |
| 253 | LRMR | Larimar Therapeutics, Inc. | 395.61M | 2.99% | 295,154 | - |
| 254 | LXEO | Lexeo Therapeutics, Inc. | 394.18M | 2.03% | 50,599 | - |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 385.30M | 2.12% | 74,491 | 9.01M |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 383.27M | 1.15% | 320,934 | - |
| 257 | VSTM | Verastem, Inc. | 381.37M | 3.09% | 733,270 | 49.59M |
| 258 | CMPX | Compass Therapeutics, Inc. | 372.78M | 0.49% | 346,362 | 850.00K |
| 259 | VNDA | Vanda Pharmaceuticals Inc. | 362.02M | 1.18% | 165,388 | 217.78M |
| 260 | AVIR | Atea Pharmaceuticals, Inc. | 361.72M | 0.89% | 38,359 | - |
| 261 | FENC | Fennec Pharmaceuticals Inc. | 358.14M | 0.10% | 63,804 | 51.00M |
| 262 | UPB | Upstream Bio, Inc. | 355.91M | 3.48% | 90,372 | 3.32M |
| 263 | DMAC | DiaMedica Therapeutics Inc. | 354.01M | 4.62% | 41,757 | - |
| 264 | OABI | OmniAb, Inc. | 353.01M | 4.51% | 77,343 | 28.94M |
| 265 | PALI | Palisade Bio, Inc. | 338.48M | 0.52% | 274,727 | - |
| 266 | GLSI | Greenwich LifeSciences, Inc. | 337.09M | -0.28% | 17,013 | - |
| 267 | ABEO | Abeona Therapeutics Inc. | 327.72M | 0.52% | 284,355 | 14.54M |
| 268 | IRD | Opus Genetics, Inc. | 323.95M | -2.45% | 147,246 | 11.98M |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 321.25M | 0.80% | 64,844 | 1.00 |
| 270 | LCTX | Lineage Cell Therapeutics, Inc. | 317.86M | 2.00% | 185,972 | 14.78M |
| 271 | ELDN | Eledon Pharmaceuticals, Inc. | 306.89M | 0.51% | 682,843 | - |
| 272 | NAUT | Nautilus Biotechnology, Inc. | 302.45M | 2.15% | 85,513 | - |
| 273 | LYEL | Lyell Immunopharma, Inc. | 298.44M | 1.27% | 6,620 | 31.00K |
| 274 | IMRX | Immuneering Corporation | 296.96M | 1.10% | 437,006 | - |
| 275 | SABS | SAB Biotherapeutics, Inc. | 296.68M | 0.26% | 142,208 | 114.70K |
| 276 | MGNX | MacroGenics, Inc. | 296.52M | -0.53% | 434,800 | 157.08M |
| 277 | RNAC | Cartesian Therapeutics, Inc. | 295.28M | -1.28% | 51,346 | 1.78M |
| 278 | IFRX | InflaRx N.V. | 293.85M | 3.37% | 134,637 | 33.82K |
| 279 | SRZN | Surrozen, Inc. | 292.06M | 1.19% | 31,715 | 7.49M |
| 280 | BCYC | Bicycle Therapeutics plc | 285.53M | 2.25% | 22,607 | 63.50M |
| 281 | NMRA | Neumora Therapeutics, Inc. | 285.34M | -4.35% | 377,800 | - |
| 282 | IVVD | Invivyd, Inc. | 281.73M | 2.32% | 624,914 | 55.87M |
| 283 | NAGE | Niagen Bioscience, Inc. | 277.74M | 2.96% | 118,394 | 130.42M |
| 284 | CNXU | Conexeu Sciences Inc. | 276.95M | -1.90% | 26,737 | - |
| 285 | ADAG | Adagene Inc. | 268.25M | 2.01% | 249,388 | 7.67M |
| 286 | TRDA | Entrada Therapeutics, Inc. | 267.37M | 2.49% | 33,949 | 5.74M |
| 287 | ZNTL | Zentalis Pharmaceuticals, Inc. | 265.53M | 1.36% | 483,915 | 26.87M |
| 288 | FATE | Fate Therapeutics, Inc. | 264.59M | 5.09% | 1,442,968 | 6.32M |
| 289 | FULC | Fulcrum Therapeutics, Inc. | 262.87M | 2.47% | 325,639 | 80.00M |
| 290 | HELP | Cybin Inc. | 253.68M | 4.54% | 1,353,062 | - |
| 291 | ARMP | Armata Pharmaceuticals, Inc. | 251.47M | -2.28% | 8,860 | 5.20M |
| 292 | AVXL | Anavex Life Sciences Corp. | 245.12M | 2.52% | 167,620 | - |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 244.91M | 1.24% | 39,858 | 32.72M |
| 294 | ACIU | AC Immune SA | 244.53M | 0.61% | 11,049 | 4.62M |
| 295 | FHTX | Foghorn Therapeutics Inc. | 240.73M | -0.97% | 22,980 | 28.22M |
| 296 | GALT | Galectin Therapeutics Inc. | 238.40M | 16.03% | 422,688 | - |
| 297 | ALXO | ALX Oncology Holdings Inc. | 238.18M | 0.57% | 149,403 | - |
| 298 | SLGL | Sol-Gel Technologies Ltd. | 236.02M | 1.32% | 24,660 | 18.47M |
| 299 | CHRS | Coherus Oncology, Inc. | 234.46M | 4.11% | 200,560 | 46.88M |
| 300 | WHWK | Whitehawk Therapeutics, Inc. | 228.04M | -2.97% | 139,669 | 7.15M |
| 301 | CAMP | Camp4 Therapeutics Corporation | 227.44M | 0.46% | 19,178 | 3.93M |
| 302 | TARA | Protara Therapeutics, Inc. | 226.50M | 0.75% | 76,424 | - |
| 303 | VYGR | Voyager Therapeutics, Inc. | 224.77M | 0.54% | 99,722 | 36.49M |
| 304 | KPTI | Karyopharm Therapeutics Inc. | 223.00M | 1.97% | 82,964 | 151.12M |
| 305 | RNA | Atrium Therapeutics, Inc. | 222.20M | 1.41% | 33,888 | 36.68M |
| 306 | KROS | Keros Therapeutics, Inc. | 221.57M | 1.77% | 36,186 | 33.18M |
| 307 | NKTX | Nkarta, Inc. | 218.21M | 0.66% | 119,460 | - |
| 308 | NGEN | NervGen Pharma Corp. | 215.59M | -1.46% | 173,842 | - |
| 309 | UNCY | Unicycive Therapeutics, Inc. | 215.20M | 0.50% | 368,519 | - |
| 310 | CDXS | Codexis, Inc. | 214.97M | -1.05% | 193,520 | 78.09M |
| 311 | KRRO | Korro Bio, Inc. | 208.98M | 5.69% | 146,337 | 3.84M |
| 312 | CLLS | Cellectis S.A. | 207.27M | -4.83% | 6,898 | 75.11M |
| 313 | ARCT | Arcturus Therapeutics Holdings Inc. | 205.50M | 2.12% | 162,052 | 54.71M |
| 314 | CNTN | Canton Strategic Holdings, Inc. | 204.53M | -9.29% | 482,084 | - |
| 315 | IMUX | Immunic, Inc. | 204.19M | -0.53% | 61,672 | - |
| 316 | NERV | Minerva Neurosciences, Inc. | 203.59M | 0.46% | 17,676 | - |
| 317 | ALEC | Alector, Inc. | 203.18M | - | 66,357 | 18.42M |
| 318 | OTLK | Outlook Therapeutics, Inc. | 200.03M | -2.65% | 3,104,655 | 333.14K |
| 319 | QTTB | Q32 Bio Inc. | 195.51M | -2.95% | 82,356 | 53.74M |
| 320 | PRQR | ProQR Therapeutics N.V. | 194.92M | -2.12% | 62,026 | 15.73M |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 190.97M | 0.17% | 99,016 | 17.56M |
| 322 | CGEN | Compugen Ltd. | 190.12M | -0.50% | 21,468 | 72.66M |
| 323 | MDWD | MediWound Ltd. | 189.89M | 5.01% | 16,728 | 14.48M |
| 324 | NBP | NovaBridge Biosciences | 187.93M | 0.93% | 52,069 | - |
| 325 | ANTX | AN2 Therapeutics, Inc. | 182.78M | 1.91% | 71,372 | - |
| 326 | DTIL | Precision BioSciences, Inc. | 181.52M | 1.22% | 35,194 | 45.07M |
| 327 | LENZ | LENZ Therapeutics, Inc. | 180.29M | - | 270,963 | 20.99M |
| 328 | IPHA | Innate Pharma S.A. | 179.43M | -1.59% | 1,827 | 10.57M |
| 329 | TTRX | Turn Therapeutics Inc. | 178.73M | 0.17% | 3,418 | - |
| 330 | PLX | Protalix BioTherapeutics, Inc. | 176.85M | 1.15% | 90,851 | 76.38M |
| 331 | EQ | Equillium, Inc. | 175.77M | -2.11% | 175,875 | 4.39M |
| 332 | MIST | Milestone Pharmaceuticals Inc. | 175.50M | -0.77% | 210,590 | 1.78M |
| 333 | OKUR | OnKure Therapeutics, Inc. | 172.89M | 1.90% | 36,413 | - |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 172.62M | -0.83% | 93,664 | - |
| 335 | ORMP | Oramed Pharmaceuticals Inc. | 171.68M | 0.60% | 26,369 | 2.00M |
| 336 | KZIA | Kazia Therapeutics Limited | 170.72M | 1.70% | 73,914 | 1.27M |
| 337 | YDES | YD Bio Limited | 168.77M | -6.98% | 22,188 | 510.36K |
| 338 | CRBU | Caribou Biosciences, Inc. | 168.61M | 2.41% | 515,314 | 11.20M |
| 339 | HURA | TuHURA Biosciences, Inc. | 167.49M | -0.38% | 56,368 | - |
| 340 | TNYA | Tenaya Therapeutics, Inc. | 161.57M | 2.56% | 594,233 | 225.00K |
| 341 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 159.89M | 2.01% | 61,858 | - |
| 342 | HUMA | Humacyte, Inc. | 155.66M | 0.10% | 7,047,604 | 2.02M |
| 343 | ENLV | Enlivex Ltd. | 146.44M | -0.54% | 68,990 | - |
| 344 | TLSA | Tiziana Life Sciences Ltd | 144.82M | -3.45% | 23,763 | - |
| 345 | ADCT | ADC Therapeutics SA | 144.36M | -1.30% | 158,259 | 79.18M |
| 346 | MOLN | Molecular Partners AG | 143.65M | 0.26% | 11,731 | 856.30K |
| 347 | ACOG | Alpha Cognition Inc. | 143.16M | - | 9,787 | 10.83M |
| 348 | SPRB | Spruce Biosciences, Inc. | 143.01M | -0.35% | 5,244 | 697.00K |
| 349 | PYXS | Pyxis Oncology, Inc. | 137.80M | 3.57% | 123,622 | 13.86M |
| 350 | NRXP | NRx Pharmaceuticals, Inc. | 136.46M | 0.27% | 120,720 | 2.29M |
| 351 | CNTB | Connect Biopharma Holdings Limited | 131.59M | - | 100,285 | 233.00K |
| 352 | GNLX | Genelux Corporation | 129.23M | -0.34% | 19,795 | 8.00K |
| 353 | COYA | Coya Therapeutics, Inc. | 126.55M | 0.09% | 48,097 | 7.94M |
| 354 | SPRO | Spero Therapeutics, Inc. | 126.51M | 1.63% | 359,436 | 61.19M |
| 355 | GUTS | Fractyl Health, Inc. | 126.27M | -3.76% | 197,836 | 3.00K |
| 356 | AGEN | Agenus Inc. | 124.51M | -2.61% | 132,971 | 123.87M |
| 357 | PEPG | PepGen Inc. | 124.50M | -1.10% | 79,656 | - |
| 358 | MENS | Jyong Biotech Ltd. | 122.49M | 0.61% | 89,747 | - |
| 359 | ALDX | Aldeyra Therapeutics, Inc. | 120.04M | -1.49% | 356,954 | - |
| 360 | NTHI | NeOnc Technologies Holdings, Inc. | 119.75M | -3.07% | 4,749 | 39.99K |
| 361 | ENGN | enGene Therapeutics Inc. | 117.90M | 2.92% | 332,211 | - |
| 362 | PLYX | Polaryx Therapeutics, Inc. | 116.46M | 2.07% | 23,587 | - |
| 363 | ONCY | Oncolytics Biotech Inc. | 112.46M | 0.14% | 359,054 | - |
| 364 | ALPS | Alps Group Inc | 108.98M | 0.75% | 129,536 | 3.74M |
| 365 | KLRS | Kalaris Therapeutics, Inc. | 105.88M | -0.45% | 16,508 | - |
| 366 | CBUS | Cibus, Inc. | 105.34M | 0.73% | 12,186 | 4.29M |
| 367 | FBIO | Fortress Biotech, Inc. | 105.14M | 0.16% | 152,095 | 66.16M |
| 368 | CUE | Cue Biopharma, Inc. | 104.78M | -3.72% | 5,488 | 32.73M |
| 369 | VANI | Vivani Medical, Inc. | 103.53M | 0.88% | 75,250 | - |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 102.39M | 5.49% | 2,314 | 37.16M |
| 371 | PTHS | Pelthos Therapeutics Inc. | 100.83M | -1.66% | 2,895 | 27.70M |
| 372 | CGTX | Cognition Therapeutics, Inc. | 99.34M | -32.73% | 4,148,567 | - |
| 373 | ATRA | Atara Biotherapeutics, Inc. | 97.13M | -3.41% | 2,775 | 23.14M |
| 374 | SEER | Seer, Inc. | 95.63M | 0.54% | 17,770 | 15.17M |
| 375 | AARD | Aardvark Therapeutics, Inc. | 95.15M | 3.11% | 23,490 | - |
| 376 | BDTX | Black Diamond Therapeutics, Inc. | 94.55M | 2.48% | 262,291 | 70.00M |
| 377 | ANIX | Anixa Biosciences, Inc. | 94.41M | 0.54% | 73,404 | - |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 93.79M | 0.88% | 787,027 | 65.34K |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 93.49M | -0.04% | 293,278 | 3.17M |
| 380 | PYPD | PolyPid Ltd. | 92.99M | -2.81% | 86,296 | - |
| 381 | PMN | ProMIS Neurosciences, Inc. | 91.47M | -4.58% | 5,442 | - |
| 382 | CSBR | Champions Oncology, Inc. | 90.68M | 4.82% | 2,334 | 57.95M |
| 383 | BMEA | Biomea Fusion, Inc. | 90.37M | 1.63% | 242,723 | - |
| 384 | RNTX | Rein Therapeutics Inc. | 90.29M | 0.19% | 29,561 | - |
| 385 | ICCC | ImmuCell Corporation | 89.88M | 0.71% | 16,386 | 29.93M |
| 386 | CRDF | Cardiff Oncology, Inc. | 87.86M | 2.80% | 71,716 | 525.00K |
| 387 | ACET | Adicet Bio, Inc. | 87.47M | 2.21% | 26,066 | - |
| 388 | MAIA | MAIA Biotechnology, Inc. | 87.25M | 3.99% | 299,501 | - |
| 389 | ATHE | Alterity Therapeutics Limited | 86.63M | 3.83% | 7,259 | 4.43M |
| 390 | NRXS | NeurAxis, Inc. | 86.20M | -0.57% | 23,124 | 4.28M |
| 391 | GOSS | Gossamer Bio, Inc. | 86.09M | 2.74% | 4,031,220 | 55.54M |
| 392 | LIXT | Lixte Biotechnology Holdings, Inc. | 86.06M | -4.79% | 145,101 | - |
| 393 | TELO | Telomir Pharmaceuticals, Inc. | 85.97M | - | 8,976 | - |
| 394 | OKYO | OKYO Pharma Limited | 84.49M | 1.90% | 11,244 | - |
| 395 | RLYB | Rallybio Corporation | 83.60M | 0.51% | 7,601 | 858.00K |
| 396 | OSTX | OS Therapies Incorporated | 81.50M | 0.55% | 65,814 | - |
| 397 | IBIO | iBio, Inc. | 81.47M | -0.61% | 101,222 | 300.00K |
| 398 | HRTX | Heron Therapeutics, Inc. | 80.31M | 1.36% | 240,018 | 150.71M |
| 399 | LONA | LeonaBio, Inc. | 78.91M | 0.60% | 570 | - |
| 400 | HYFT | MindWalk Holdings Corp. | 78.47M | 6.04% | 146,082 | 20.70M |
| 401 | GANX | Gain Therapeutics, Inc. | 77.63M | 2.82% | 115,162 | - |
| 402 | ENTX | Entera Bio Ltd. | 77.53M | 1.61% | 257,669 | 42.00K |
| 403 | ELTX | Elicio Therapeutics, Inc. | 74.32M | -1.70% | 265,404 | - |
| 404 | ANVS | Annovis Bio, Inc. | 74.02M | - | 163,171 | - |
| 405 | PLRX | Pliant Therapeutics, Inc. | 71.83M | - | 17,466 | - |
| 406 | XBIT | XBiotech Inc. | 71.65M | 0.86% | 4,552 | - |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 70.19M | 0.61% | 85,538 | - |
| 408 | BYSI | BeyondSpring Inc. | 67.85M | 2.48% | 3,008 | 1.88M |
| 409 | IMA | ImageneBio, Inc. | 67.79M | - | 269 | 800.00K |
| 410 | MCRB | Seres Therapeutics, Inc. | 67.30M | -1.42% | 11,541 | 1.15M |
| 411 | MNOV | MediciNova, Inc. | 67.19M | 0.37% | 9,743 | 596.64K |
| 412 | EDSA | Edesa Biotech, Inc. | 66.33M | -2.36% | 36,665 | - |
| 413 | PMVP | PMV Pharmaceuticals, Inc. | 65.06M | 0.83% | 98,903 | - |
| 414 | CING | Cingulate Inc. | 63.06M | -1.66% | 72,378 | - |
| 415 | INKT | MiNK Therapeutics, Inc. | 61.28M | -0.24% | 2,053 | - |
| 416 | EXOZ | eXoZymes, Inc. | 60.78M | -6.91% | 213 | -700.00 |
| 417 | BOLD | Boundless Bio, Inc. | 60.09M | 2.88% | 1,304,480 | - |
| 418 | TCRX | TScan Therapeutics, Inc. | 59.63M | -0.92% | 99,542 | 9.14M |
| 419 | KALA | KALA BIO, Inc. | 59.51M | 2.61% | 16,309 | - |
| 420 | IBO | Impact BioMedical Inc. | 58.59M | 1.02% | 5,654 | 39.00K |
| 421 | FLNA | Filana Therapeutics, Inc. | 57.73M | 0.42% | 28,944 | - |
| 422 | CNTX | Context Therapeutics Inc. | 56.97M | -4.86% | 642,092 | - |
| 423 | ATYR | aTyr Pharma, Inc. | 56.38M | 7.06% | 1,610,361 | 190.00K |
| 424 | VRXA | Veraxa Biotech AG | 55.48M | -24.40% | 487,684 | - |
| 425 | DWTX | Dogwood Therapeutics, Inc. | 53.98M | 3.55% | 14,222 | - |
| 426 | XLO | Xilio Therapeutics, Inc. | 53.67M | 0.79% | 4,277 | 53.48M |
| 427 | HYPD | Hyperion DeFi, Inc. | 53.36M | -4.09% | 331,333 | 1.04M |
| 428 | IMMP | Immutep Limited | 53.08M | -1.68% | 104,041 | 5.28M |
| 429 | TIL | Instil Bio, Inc. | 51.68M | 0.79% | 1,310 | - |
| 430 | PDSB | PDS Biotechnology Corporation | 51.07M | 0.33% | 90,133 | - |
| 431 | LTRN | Lantern Pharma Inc. | 50.71M | 4.18% | 50,101 | - |
| 432 | MREO | Mereo BioPharma Group plc | 49.32M | -4.13% | 469,664 | 500.00K |
| 433 | ELOX | Eloxx Pharmaceuticals, Inc. | 49.28M | - | 5,113 | - |
| 434 | ACTU | Actuate Therapeutics, Inc. | 48.81M | 5.69% | 20,743 | - |
| 435 | MGX | Metagenomi Therapeutics, Inc. | 47.55M | 1.85% | 12,174 | 22.33M |
| 436 | VERU | Veru Inc. | 47.35M | -2.96% | 101,443 | 16.89M |
| 437 | RADX | Radiopharm Theranostics Limited | 46.64M | -2.05% | 19,396 | 10.86M |
| 438 | APLM | Apollomics, Inc. | 46.12M | 4.53% | 2,583 | 8.84M |
| 439 | RNXT | RenovoRx, Inc. | 42.97M | 4.61% | 76,304 | 1.49M |
| 440 | GNTA | Genenta Science S.p.A. | 42.70M | -1.63% | 55,281 | - |
| 441 | ESLA | Estrella Immunopharma, Inc. | 42.39M | -1.50% | 7,848 | - |
| 442 | TVGN | Tevogen Bio Holdings Inc. | 40.30M | 1.21% | 2,193 | - |
| 443 | INMB | INmune Bio Inc. | 39.35M | 4.23% | 127,448 | 50.00K |
| 444 | GRCE | Grace Therapeutics, Inc. | 38.89M | - | 45,302 | - |
| 445 | NTRB | Nutriband Inc. | 37.27M | 0.51% | 9,424 | 1.80M |
| 446 | ABVC | ABVC BioPharma, Inc. | 34.87M | 5.34% | 43,500 | 797.92K |
| 447 | ALGS | Aligos Therapeutics, Inc. | 34.84M | -0.35% | 15,566 | 4.71M |
| 448 | GRDX | GridAI Technologies Corp. | 32.39M | 5.85% | 21,426 | - |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 32.16M | 0.49% | 16,344 | 90.00K |
| 450 | LSTA | Lisata Therapeutics, Inc. | 31.69M | 0.29% | 7,741 | 170.00K |
| 451 | DARE | Daré Bioscience, Inc. | 30.78M | -0.72% | 94,449 | 1.16M |
| 452 | CRVO | CervoMed Inc. | 30.74M | -10.75% | 655,187 | 2.09M |
| 453 | NNVC | NanoViricides, Inc. | 30.07M | 0.76% | 45,533 | - |
| 454 | SNTI | Senti Biosciences Holdings, Inc. | 29.90M | 3.83% | 91,596 | 38.00K |
| 455 | LITS | Lite Strategy, Inc. | 29.75M | -1.75% | 87,681 | - |
| 456 | DYAI | Dyadic International, Inc. | 29.37M | - | 28,073 | 3.81M |
| 457 | EVAX | Evaxion A/S | 28.98M | 2.51% | 1,055 | 7.53M |
| 458 | SER | Serina Therapeutics, Inc. | 28.80M | - | 12,456 | 130.00K |
| 459 | BRNS | Barinthus Biotherapeutics plc | 28.26M | 3.24% | 651 | 14.97M |
| 460 | KYNB | Kyntra Bio, Inc. | 27.95M | -0.93% | 548 | 7.44M |
| 461 | PSTV | Plus Therapeutics, Inc. | 27.39M | -2.45% | 35,427 | 5.18M |
| 462 | NRSN | NeuroSense Therapeutics Ltd. | 27.20M | 0.22% | 26,880 | - |
| 463 | IGC | IGC Pharma, Inc. | 26.58M | 0.23% | 103,798 | 1.11M |
| 464 | BCTX | BriaCell Therapeutics Corp. | 25.92M | 1.53% | 23,432 | - |
| 465 | VTGN | Vistagen Therapeutics, Inc. | 25.87M | -0.28% | 193,433 | 1.27M |
| 466 | QNTM | Quantum BioPharma Ltd. | 25.69M | 8.83% | 203,808 | - |
| 467 | SKYE | Skye Bioscience, Inc. | 24.42M | -0.71% | 21,235 | - |
| 468 | LGVN | Longeveron Inc. | 24.29M | -2.50% | 27,314 | 1.22M |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 23.73M | 0.72% | 5,734 | -13.27K |
| 470 | MRKR | Marker Therapeutics, Inc. | 22.84M | - | 9,334 | 3.55M |
| 471 | PLRZ | Polyrizon Ltd. | 22.65M | 2.54% | 4,952 | - |
| 472 | TVRD | Tvardi Therapeutics, Inc. | 22.52M | -0.83% | 15,437 | - |
| 473 | VYNE | VYNE Therapeutics Inc. | 22.47M | 3.66% | 61,127 | 454.00K |
| 474 | PLUR | Pluri Inc. | 22.23M | -1.67% | 126 | 1.08M |
| 475 | LPCN | Lipocine Inc. | 20.78M | -0.40% | 19,861 | 2.00M |
| 476 | ALLR | Allarity Therapeutics, Inc. | 20.68M | -1.52% | 37,011 | 345.00K |
| 477 | CELU | Celularity Inc. | 20.26M | 0.03% | 65,701 | 26.55M |
| 478 | PTN | Palatin Technologies, Inc. | 20.18M | -6.33% | 7,113 | 12.88M |
| 479 | CLRB | Cellectar Biosciences, Inc. | 20.14M | 0.80% | 3,898 | - |
| 480 | PASG | Passage Bio, Inc. | 19.66M | 0.17% | 25,338 | - |
| 481 | KTTA | Pasithea Therapeutics Corp. | 19.51M | 2.80% | 45,279 | - |
| 482 | NCEL | NewcelX Ltd. | 19.27M | 1.13% | 1,826 | - |
| 483 | TPST | Tempest Therapeutics, Inc. | 18.66M | 0.40% | 121,782 | - |
| 484 | CVM | CEL-SCI Corporation | 18.53M | 3.92% | 456,190 | - |
| 485 | LNAI | Lunai Bioworks Inc. | 18.45M | -5.35% | 109,047 | 20.94K |
| 486 | AEON | AEON Biopharma, Inc. | 18.41M | 1.13% | 1,269 | - |
| 487 | XCUR | Exicure, Inc. | 18.23M | 4.76% | 14,663 | 500.00K |
| 488 | HOWL | Werewolf Therapeutics, Inc. | 18.13M | 3.12% | 253,503 | 1.14M |
| 489 | GTBP | GT Biopharma, Inc. | 17.22M | -3.30% | 549,567 | - |
| 490 | MLEC | Moolec Science SA | 16.85M | 1.25% | 2,805 | 7.83M |
| 491 | ATOS | Atossa Therapeutics, Inc. | 15.84M | -3.16% | 57,139 | - |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 15.81M | 2.81% | 79,334 | 5.61M |
| 493 | QNCX | Quince Therapeutics, Inc. | 15.70M | -0.51% | 51,266 | - |
| 494 | MBRX | Moleculin Biotech, Inc. | 15.45M | 5.28% | 506,249 | - |
| 495 | BIVI | BioVie Inc. | 14.90M | 1.80% | 34,070 | - |
| 496 | INAB | IN8bio, Inc. | 14.87M | 3.42% | 15,560 | - |
| 497 | HIND | Vyome Holdings, Inc. | 14.74M | -0.94% | 25,910 | 152.72K |
| 498 | COCP | Cocrystal Pharma, Inc. | 14.61M | - | 48,371 | 225.00K |
| 499 | JSPR | Jasper Therapeutics, Inc. | 14.21M | 3.78% | 71,472 | - |
| 500 | CRIS | Curis, Inc. | 14.12M | -2.38% | 169,532 | 7.06M |